1) radiation-induced lung injury
放射性肺损伤
1.
Study of plasma transforming growth factor β1 change in rats with radiation-induced lung injury;
大鼠放射性肺损伤血浆TGF-β_1变化研究
2.
Analysis of radiation-induced lung injury after lung cancer radiotherapy;
肺癌放疗所致放射性肺损伤的相关因素分析
3.
To establish rat model of semi-thorax radiation-induced lung injury with high dose irradiation.
建立单次大剂量致大鼠半胸放射性肺损伤的动物模型，动态观察放射性肺损伤的病理形态学变化。
2) Radiation pulmonary injury
放射性肺损伤
1.
Studies on progression of radiation pulmonary injury in C57BL/6J and C3H/HeN mice and the underlying mechanism by yissue microarray;
利用组织芯片技术研究C57BL/6J和C3H/HeN小鼠放射性肺损伤进程差异及其机制
2.
Objective To explore appropriate therapy with traditional Chinese medicine for radiation pulmonary injury.
目的探讨中医药对放射性肺损伤的防治方法。
3) radiation induced lung injury
放射性肺损伤
1.
AIM To investigate the effects of fluvastatin on transforming growth factor beta 1 (TGF beta 1) in rats with radiation induced lung injury.
目的 探讨氟伐他汀 (fluvastatin)对放射性肺损伤TGF-β1 表达的影响 。
2.
Objective:By the analysis of the clinical data,radiotherapy data and prognosis data,and serum cytokines detection in NSCLC patients,picking out the factors associated with radiation induced lung injury.
目的:通过对非小细胞肺癌病人的一般临床资料、放疗及预后情况全面分析,结合相关血清细胞因子检测,筛选放射性肺损伤发生发展的相关因素,建立统计学PI预测模型,并用于放疗患者的验证和预测,以指导临床。
3.
Purpose:To analyze the relationship of radiation induced lung injury and the dose of irradiated lung in Hodgkin\'s lymphoma patients who have received mediastinal irradiation;and to estimate the differences of the dose and volume of the irradiated lung among the three different radiation treatment plannings(2D mantle field,3DCRT and sIMRT) in lymphoma patients.
目的:分析霍奇金淋巴瘤患者纵隔放疗时放射性肺损伤的发生与剂量学的关系;比较在三种不同的照射方式下肺所受的照射剂量体积关系(二维斗篷野照射、三维适形放疗、简单调强放疗)。
4) Radiation-induced pulmonary injury
放射性肺损伤
1.
Objective:This clinical study investigated whethe daily pretreatment with beilai combined with pulmonary carcinoma mixture could reduce the incidence of radiation-induced pulmonary injury.
目的:对贝莱联合肺癌合剂在老年性肺癌放疗中减轻放射性肺损伤的疗效进行评价。
2.
Objective:To study the effect of ZhongFeiHeJi acting on the expressing of MMP-9 /TIMP-1 in the lung tissue of rat with radiation-induced pulmonary injury lung tissue.
方法:90只Wistar大鼠随机分为正常组、模型组、中肺合剂组,6MV-X线直线加速器对大鼠双肺进行单次照射25Gy,复制大鼠放射性肺损伤模型,然后予中肺合剂灌胃,8周后分离大鼠肺脏经宏观检查并称重后,计算肺系数;取右上肺组织切片,采用SP法检测MMP-9、TIMP-1的表达。
5) Radioactivity lung injury
放射性性肺损伤
6) radiation pulmonary injuries
肺放射损伤
补充资料：放射性碘标记的放射性药物
分子式：
CAS号：
性质： 131I是最早用于临床的放射性核素之一。临床上常用的碘标放射性药物有：(1)Nal31I，用于甲状腺显像和甲亢治疗；(2)心肌显像用131I(123I)-CO-长链脂肪酸；(3)脑功能显像用123I(131I)-IMP(N-异丙基对碘安非他命，N-isopropyl-p-iodoamphetamine)，123I(131I)-HIPDM[N，N,N′-trimethyl-N′-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine]；(4)受体显像用123I(131I)标记变体配体，如D1，D2，乙酰胆碱，安定类受体显像剂；(5)用于放射免疫显像和治疗的131I标记抗肿病抗体；(6)肾上腺显像剂131I-6-碘胆固醇、131I-间-碘苄胍等。
CAS号：
性质： 131I是最早用于临床的放射性核素之一。临床上常用的碘标放射性药物有：(1)Nal31I，用于甲状腺显像和甲亢治疗；(2)心肌显像用131I(123I)-CO-长链脂肪酸；(3)脑功能显像用123I(131I)-IMP(N-异丙基对碘安非他命，N-isopropyl-p-iodoamphetamine)，123I(131I)-HIPDM[N，N,N′-trimethyl-N′-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine]；(4)受体显像用123I(131I)标记变体配体，如D1，D2，乙酰胆碱，安定类受体显像剂；(5)用于放射免疫显像和治疗的131I标记抗肿病抗体；(6)肾上腺显像剂131I-6-碘胆固醇、131I-间-碘苄胍等。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条